IMV
IMV is a Canadian biopharmaceutical company focused on developing immunotherapies for serious human diseases using its proprietary lipid-based delivery system, which the company calls DPX.
Key facts
| Business Model | Commerce |
|---|---|
| Legal Name | IMV Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/imv |
| Full Address | 130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia, B3B 2C4 Canada |
| LinkedIn URL | https://www.linkedin.com/company/immunovaccine-inc- |
| Pitchbook URL | https://pitchbook.com/profiles/company/59853-61 |
| Previous Name | Immunovaccine Inc. |
| Stock Symbol | IMV |
| Ticker Symbol | IMV |
| Twitter URL | https://twitter.com/imv_inc |
| Official Website | https://imv-inc.com |
| YouTube Channel | https://www.youtube.com/channel/UCPEqfb6oPValp6PcTIsTX4g |
Contact details
Email and phone for IMV are available to signed-in members of PharmaLyt.
Sign in to view